Retium Tablets (Dovesil Acid Calcium Hydrate)

Adult dose

Adults: Administer the following doses orally, as calcium dobesilate hydrate. 1. Vascular damage and retinopathy: 500-1000mg daily 2. Venous disease: Administer 750mg daily for 1-3 weeks, then administer 500mg daily. Take after meals with plenty of fluids. The dose may be adjusted according to age and symptoms.

This medication should not be used by individuals who are allergic to this drug or its components. Caution is required when used in patients with poor renal function. This drug is excreted through the kidneys, so the dosage may need to be reduced in patients with severely impaired renal function. Caution is also necessary for patients with impaired liver function. If liver function deteriorates, liver enzyme levels may rise, and in such cases, the benefits and risks of treatment should be reassessed. This medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks in individuals allergic to sulfites, so caution is advised. Rarely, this medication may cause abnormalities in the blood. If there are symptoms such as high fever or signs of infection, the patient should immediately inform a physician, and blood tests should be conducted to check the condition. Furthermore, if hypersensitivity reactions such as skin rashes, itching, hives, or facial swelling occur, the patient should stop taking the drug immediately and seek medical attention. Common side effects may include headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, muscle pain, fever, chills, lethargy, and fatigue. If these symptoms are severe, the dosage may need to be reduced or the medication temporarily stopped. The effects on driving or machine operation are unclear, so caution is needed. Women who are pregnant or breastfeeding are advised not to use this medication; especially during breastfeeding, the drug should be discontinued or breastfeeding stopped. The safety and efficacy of this medication have not been sufficiently studied in children, so its use is not recommended. There are no specific precautions for elderly patients over 65, but they should always take the medication according to their physician's instructions. This medication may affect certain blood test results, so it is advisable to conduct tests before starting the medication.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial edema
• anaphylactic reaction
• headache

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve the medication's effectiveness for a long time.

Appearance

White rectangular tablets

Package unit

90 tablets (10 tablets/PTP × 9), 120 tablets (10 tablets/PTP × 12)